BioRon Eastman joined EW in 2006 as a Partner, and was appointed Managing Director in 2008. Mr. Eastman led and served on the Board of Directors of EW’s growth equity investment in ProteinSimple (acquired by Bio-Techne). He currently serves on the Board of Directors of EW portfolio companies Elusys, Corium, EyePoint Pharmaceuticals, Suneva and Symphogen. Mr. Eastman has over 40 years of experience in building healthca ....
Education